Skip to main content
. 2022 Jan 19;11(3):e023391. doi: 10.1161/JAHA.121.023391

Table 2.

Primary and Secondary Clinical Outcomes

Early rhythm control (n=178)

Usual care

(n=95)

HR 95% CI P value
Primary outcome, n (%)*
Recurrent stroke in 3 mo 2 (1.1) 4 (4.2) 0.257 0.047–1.405 0.117
Recurrent stroke in 12 mo 3 (1.7) 6 (6.3) 0.251 0.063–1.003 0.050
Secondary outcome, n (%)**
Composite outcome in 3 mo 19 (10.7) 10 (10.5) 0.995 0.463–2.140 0.990
Composite outcome in 12 mo 25 (14.0) 16 (16.8) 0.808 0.431–1.513 0.505
Arrhythmia‐related events in 3 mo 3 (1.7) 0 NA NA NA
Arrhythmia‐related events in 12 mo 5 (2.8) 1 (1.1) 2.565 0.3–21.958 0.390
Sustained AF 60 (34.1) 59 (62.8) <0.001
AF detection period in the consecutive Holter during 12 mo, mo 3.0 (1.0–9.0) 7.0 (1.0–12.0) 0.002
Stroke to NSR duration, d 13.0 (2.0–84.0) 2.0 (0.0–98.5) 0.083

AF indicates atrial fibrillation; HR, hazard ratio; NA, not available; and NSR, normal sinus rhythm.

*

Primary: recurrent ischemic stroke (IS), recurrent IS in 3 and 12 months.

**

Secondary: a composite of death from any cause or hospitalization for any cause, recurrent stroke, and arrhythmia‐related events.